Pages that link to "Q27347951"
Jump to navigation
Jump to search
The following pages link to c-Myc accelerates S-phase and requires WRN to avoid replication stress (Q27347951):
Displaying 45 items.
- BRD7 is a candidate tumour suppressor gene required for p53 function (Q24303120) (← links)
- Unbalanced replication as a major source of genetic instability in cancer cells (Q24621737) (← links)
- Roles of Werner syndrome protein in protection of genome integrity (Q24643050) (← links)
- Synthetic lethal screens as a means to understand and treat MYC-driven cancers (Q27006010) (← links)
- MYC and the control of DNA replication (Q33653686) (← links)
- Delineation of WRN helicase function with EXO1 in the replicational stress response (Q33945750) (← links)
- Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state. (Q34124945) (← links)
- Cdc6 cooperates with c-Myc to promote genome instability and epithelial to mesenchymal transition EMT in zebrafish (Q34227699) (← links)
- MYC-regulated genes involved in liver cell dysplasia identified in a transgenic model of liver cancer (Q34288613) (← links)
- The Triform algorithm: improved sensitivity and specificity in ChIP-Seq peak finding (Q34349554) (← links)
- Association between polymorphism rs6983267 and gastric cancer risk in Chinese population (Q34772076) (← links)
- Myc-dependent genome instability and lifespan in Drosophila (Q34990194) (← links)
- Identification and pharmacological inactivation of the MYCN gene network as a therapeutic strategy for neuroblastic tumor cells (Q35002896) (← links)
- Human neonatal cardiovascular progenitors: unlocking the secret to regenerative ability (Q35035279) (← links)
- A PCNA-derived cell permeable peptide selectively inhibits neuroblastoma cell growth (Q35146771) (← links)
- The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in Glioblastoma (Q35463482) (← links)
- Adeno-associated virus type 2 modulates the host DNA damage response induced by herpes simplex virus 1 during coinfection. (Q35666040) (← links)
- Expression of c-Myc and Fas correlates with perineural invasion of pancreatic cancer. (Q36003265) (← links)
- Functional genomics identifies therapeutic targets for MYC-driven cancer (Q36066213) (← links)
- YAP controls retinal stem cell DNA replication timing and genomic stability (Q36081457) (← links)
- Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions (Q36090294) (← links)
- Discovery of a Family of Genomic Sequences Which Interact Specifically with the c-MYC Promoter to Regulate c-MYC Expression. (Q36110185) (← links)
- Back to the origin: reconsidering replication, transcription, epigenetics, and cell cycle control (Q36796433) (← links)
- RNAi screening uncovers Dhx9 as a modifier of ABT-737 resistance in an Eμ-myc/Bcl-2 mouse model. (Q36797266) (← links)
- Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors (Q36972697) (← links)
- Diminished origin-licensing capacity specifically sensitizes tumor cells to replication stress. (Q37232780) (← links)
- Cdc45 is a critical effector of myc-dependent DNA replication stress. (Q37292428) (← links)
- An overview of MYC and its interactome (Q37406278) (← links)
- Two sides of the Myc-induced DNA damage response: from tumor suppression to tumor maintenance (Q37988976) (← links)
- Inhibition of MAPKs, Myc/Max, NFκB, and hypoxia pathways by Phyllanthus prevents proliferation, metastasis and angiogenesis in human melanoma (MeWo) cancer cell line. (Q39500086) (← links)
- Perturbations in the Replication Program Contribute to Genomic Instability in Cancer (Q39354510) (← links)
- MYC Modulation around the CDK2/p27/SKP2 Axis (Q39406924) (← links)
- Therapeutic Implications for the Induced Levels of Chk1 in Myc-Expressing Cancer Cells (Q39470889) (← links)
- The impact of C-MYC gene expression on gastric cancer cell (Q39658966) (← links)
- Cdk2 suppresses cellular senescence induced by the c-myc oncogene. (Q39763259) (← links)
- Evidence for reciliation of RPE1 cells in late G1 phase, and ciliary localisation of cyclin B1. (Q41994033) (← links)
- c-MYC-induced genomic instability. (Q42127661) (← links)
- Ubiquitylation of the amino terminus of Myc by SCF(β-TrCP) antagonizes SCF(Fbw7)-mediated turnover (Q42820389) (← links)
- MYC-driven tumorigenesis is inhibited by WRN syndrome gene deficiency (Q43097729) (← links)
- The WRN and MUS81 proteins limit cell death and genome instability following oncogene activation (Q44563409) (← links)
- Differential cellular responses by oncogenic levels of c-Myc expression in long-term confluent retinal pigment epithelial cells. (Q48213254) (← links)
- Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas. (Q52723228) (← links)
- Cystathionase mediates senescence evasion in melanocytes and melanoma cells. (Q54453884) (← links)
- MYC Oncogene Contributions to Release of Cell Cycle Brakes (Q64061957) (← links)
- Synthetic Lethal Interactions of RECQ Helicases (Q100517556) (← links)